VR Logo

Divi's Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1990

Chairman: Ramesh BV Nimmagadda

Managing Director: Murali K Divi

Group: Divis Labs

Listing: NSE: DIVISLAB, BSE: 532488

Headquarters: Hyderabad, Telangana

Website: www.divislaboratories.com

Key Facts

Market cap: R 81,161.71 Cr

Revenue (TTM): R 5,962.01 Cr

Earnings (TTM): R 1,596.16 Cr

Cash: R 1,093.98 Cr

Total Debt: R 33.63 Cr

Promoters' ownership: 51.97%

Liquidity: High

52 Week range: R 1,595.05 - 3,389.00

Face value: R2.00

Shares outstanding: 26,54,68,580

10 Years Aggregate:

  • CFO: 7,662.29 Cr
  • EBITDA: 12,014.24 Cr
  • Net Profit: 8,981.90 Cr

Stock Performance

Time Period Divi's Laboratories S&P BSE Sensex S&P BSE Healthcare
YTD65.88-7.9546.78
1 month-6.45-3.792.24
3 months32.178.6119.73
1 Year83.48-2.1754.74
3 Years52.896.6713.47
5 Years22.648.052.43
10 Years24.116.6412.62
As on 29-Sep-2020
Year Divi's Laboratories S&P BSE Sensex S&P BSE Healthcare
201925.1014.38-3.55
201834.775.87-5.89
201740.1527.910.49
2016-32.581.95-12.88
201532.33-5.0315.06
201440.4429.8947.43
201311.218.9822.55